Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) today announced that Pharming will present at the UBS Global Life Sciences (September 24-27, 2007) in New York.
Leiden, The Netherlands, September 21, 2006. Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) (PHARM.AS) announced today that Dr. Francis Pinto, Chief Executive Officer of Pharming will present at the UBS Global Life Sciences Conference...
Leiden, The Netherlands, September 25, 2006. Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) (PHARM.AS) presented today on its value creation and research innovation at the UBS Global Life Sciences Conference in New York.
Phishing and pharming, along with their associated identity thefts, continue to grow at an alarming rate and are wreaking major havoc on the world's economy, as well as individual financial standings. Because these scams are difficult to detect and the sums of money made by criminal organizations through these activities...
Financial institutions should begin taking measures to protect themselves from "pharming," an Internet-based threat similar to phishing, according to guidance released by the Federal Deposit Insurance Corp. in late July.
Leiden, The Netherlands, December 1, 2005. Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company will present at the 5th Annual ING European Healthcare Conference (December 6-7, 2005) in London.
Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) (PHARM.AS) announced today that it has received a grant from the US FDA's Office of Orphan Products Development OPD for the clinical development...
Business Editors LEIDEN, The Netherlands--BUSINESS WIRE--Aug. 1, 2000--Pharming Group N.V. (EASDAQ: PHAR / AEX: PHAR) announced financial interim results for its first half-year ended June 30, 2000. Financial Highlights -- Total revenues increased 75% to...
Leiden, The Netherlands, June 14, 2006. Biotech company Pharming Group NV ("Pharming" or "the Company") (Euronext: PHARM) announced today it has received orphan drug designations for recombinant human C1 inhibitor (rhC1INH) from the Food and Drug Administration FDA. The Company has obtained...
Leiden, The Netherlands, July 28, 2006. Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) (PHARM.AS) announced today that it has received a Fast Track designation on recombinant human C1 inhibitor (rhC1INH) for the treatment of hereditary angioedema HAE from the US Food and Drug...
GENZYME Corp. has acquired certain assets of Pharming NV, a Belgium-based Pharming Group subsidiary operating under a court supervised receivership, including a 70,000 square foot cGMP protein manufacturing unit being built, and a transgenic human GENZYME Corp. has acquired certain assets of Pharming...
MOUNTAIN VIEW, Calif.--BUSINESS WIRE--Jan. 24, 1995--GenPharm International's European affiliate, Gene Pharming Europe B.V., (Leiden, The Netherlands) announced Tuesday the acquisition from Biogen Inc. (Cambridge, Mass.) of U.S. patent No. 4,873,316 and corresponding U.S. and international patent filings.
SUNNYVALE, Calif. -- Teros, the global leader in Web application firewalls, today revealed version 5.2 of the Teros 100 and 200 Web Application Gateways, enhanced to protect against online fraud including phishing. New enhancements include expanded anti-fraud features that disrupt multiple stages of the online fraud life cycle. The solution...
MOUNTAIN VIEW, Calif.--BUSINESS WIRE---Jan. 24, 1995--GenPharm International's European affiliate, Gene Pharming Europe B.V., Leiden, The Netherlands, and Genzyme Transgenics Corp. (NASDAQ:GZTC), Framingham, Mass., Tuesday announced that they cross-licensed certain fundamental patent rights.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008, at 1:00 p.m. Eastern...
Dr Pinto to retire after completion of transition period Leiden, The Netherlands, September 26, 2008. Biotech companyPharming Group NV ("Pharming" or "the Company") (NYSE Euronext:PHARM) announced today that the Board of Supervisory Directors BOSDhas nominated...
ANNAPOLIS, Md., Sept. 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of Allergy and Infectious Diseases NIAID, part of the National Institutes of Health NIH, has awarded the Company a multi-year contract for up...
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
With AT&T Tech Support 360, you'll have certified, U.S. based technicians on call 24/7 to help keep your computers, connections, software and peripherals up to speed for just 82¢ a day.
